HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Badano, J. L. Articles by Lupski, J. R. Search for Related Content PubMed PubMed Citation Articles by Badano, J. L. Articles by Lupski, J. R. Related Collections Molecular Diagnostics and Genetics

New Polymorphic Short Tandem Repeats for PCR-based Charcot-Marie-Tooth Disease Type 1A Duplication Diagnosis

Departments of
¹ Molecular and Human Genetics and
² Pediatrics, Baylor College of Medicine, Houston, TX 77030.
³ The Texas Children’s Hospital, Houston, TX 77030.

^aAddress correspondence to this author at: Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Rm 609E, Houston, TX 77030. Fax 713-798-5073; e-mail jlupski{at}bcm.tmc.edu.

Background: Charcot-Marie-Tooth disease type 1A (CMT1A) accounts for 70–90% of cases of CMT1 and is most frequently caused by the tandem duplication of a 1.4-Mb genomic fragment on chromosome 17p12. Molecular diagnosis of CMT1A has been based primarily on pulsed-field electrophoresis, fluorescence in situ hybridization, polymorphic allele dosage analysis, and quantitative PCR. We sought to improve the fidelity and applicability of PCR-based diagnosis by developing a panel of novel, highly polymorphic short tandem repeats (STRs) from within the CMT1A duplicated region.

Methods: We used a recently available genomic sequence to identify potentially polymorphic simple repeats. We then amplified these sequences in a multiethnic cohort of unaffected individuals and assessed the heterozygosity and number of alleles for each STR. Highly informative markers were then tested in a set of previously diagnosed CMT1A duplication patients, and the ability to identify the genomic duplication through the presence of three bands was assessed.

Results: We identified 34 polymorphic markers, 15 of which were suitable for CMT1A diagnosis on the basis of high heterozygosity in different ethnic groups, peak uniformity, and a large number of alleles. On the basis of the fluorescent dye and allele range of each marker, we developed two panels, each of which could be analyzed concurrently. Panel 1, which comprised 10 markers, detected 37 of 39 duplications, whereas panel 2, which comprised the remaining 5 markers, identified 21 of 39 duplications. Through the combination of both panels, we identified 39 of 39 duplications in previously diagnosed CMT1A patients.

Conclusions: The newly developed 15-marker set has the capability of detecting >99% of duplications and thus is a powerful and versatile diagnostic tool.

The following articles in journals at HighWire Press have cited this article:

				A. De Vos, K. Sermon, M. De Rijcke, V. Goossens, P. Henderix, N. Van Ranst, P. Platteau, W. Lissens, P. Devroey, A. Van Steirteghem, et al. Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease type 1A Mol. Hum. Reprod., July 1, 2003; 9(7): 429 - 435. [Abstract] [Full Text] [PDF]

				D. G.B. Leonard Improved Method for Diagnosis of Charcot-Marie-Tooth Type 1A: Patent Pending? Clin. Chem., May 1, 2001; 47(5): 807 - 808. [Full Text] [PDF]